Wednesday, August 02, 2017 10:51:07 AM
Recent PIXY News
- ShiftPixy Announces Execution of Its Second Asset Purchase Agreement to Acquire a Provider of Human Capital to Several Key Industrial Clients Across Western U.S. • Business Wire • 04/02/2024 12:00:00 PM
- ShiftPixy Announces Definitive Agreement to Acquire a Northern California-Based Provider of Human Capital to Several Key Industrial Clients • Business Wire • 03/26/2024 12:00:00 PM
- ShiftPixy to Present at the Webull LIVE! with Corporate Connect: Technology Investment Webinar • Business Wire • 03/22/2024 12:30:00 PM
- ShiftPixy Commits to $100 Million Financing Terms to Initiate Its Human Capital Rollup • Business Wire • 03/20/2024 12:30:00 PM
- ShiftPixy Announces Pricing of $5 Million Offering Priced At-the-Market • Business Wire • 03/19/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:14:06 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:10:24 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/29/2024 09:23:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/22/2024 10:25:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/22/2024 11:12:59 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/03/2024 05:15:23 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/21/2023 10:23:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/14/2023 10:24:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:08:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:05:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:02:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 11:43:11 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM